AU2003245105A8 - Method for diagnosing a tumor in a patient by determining pibf - Google Patents

Method for diagnosing a tumor in a patient by determining pibf

Info

Publication number
AU2003245105A8
AU2003245105A8 AU2003245105A AU2003245105A AU2003245105A8 AU 2003245105 A8 AU2003245105 A8 AU 2003245105A8 AU 2003245105 A AU2003245105 A AU 2003245105A AU 2003245105 A AU2003245105 A AU 2003245105A AU 2003245105 A8 AU2003245105 A8 AU 2003245105A8
Authority
AU
Australia
Prior art keywords
pibf
diagnosing
tumor
patient
determining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003245105A
Other versions
AU2003245105A1 (en
Inventor
Tamas Palkovics
Julia Szekeres-Bartho
Beata Polgar
Margit Lachmann
Eszter Nagy
Tamas Henics
Christoph Klade
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Valneva Austria GmbH
Original Assignee
Intercell Austria AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intercell Austria AG filed Critical Intercell Austria AG
Publication of AU2003245105A1 publication Critical patent/AU2003245105A1/en
Publication of AU2003245105A8 publication Critical patent/AU2003245105A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003245105A 2002-05-28 2003-05-28 Method for diagnosing a tumor in a patient by determining pibf Abandoned AU2003245105A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AT8092002A ATA8092002A (en) 2002-05-28 2002-05-28 PIBF
ATA809/2002 2002-05-28
PCT/AT2003/000157 WO2003100428A2 (en) 2002-05-28 2003-05-28 Method for diagnosing a tumor in a patient by determining pibf

Publications (2)

Publication Number Publication Date
AU2003245105A1 AU2003245105A1 (en) 2003-12-12
AU2003245105A8 true AU2003245105A8 (en) 2003-12-12

Family

ID=29554778

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003245105A Abandoned AU2003245105A1 (en) 2002-05-28 2003-05-28 Method for diagnosing a tumor in a patient by determining pibf

Country Status (3)

Country Link
AT (1) ATA8092002A (en)
AU (1) AU2003245105A1 (en)
WO (1) WO2003100428A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102490714B1 (en) * 2018-12-28 2023-01-26 재단법인 아산사회복지재단 Pharmaceutical composition for preventing or treating inflammatory disease comprising pibf protein

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT410753B (en) * 2000-11-28 2003-07-25 Biodevelops Verwertung Von Liz PIBF FOR DIAGNOSIS OF TUMORS

Also Published As

Publication number Publication date
AU2003245105A1 (en) 2003-12-12
WO2003100428A2 (en) 2003-12-04
WO2003100428A3 (en) 2004-04-08
ATA8092002A (en) 2005-01-15

Similar Documents

Publication Publication Date Title
GB0417041D0 (en) Method for desinging a well completion
AU2003253722A8 (en) Method for eliminating error in tonometric measurements
EP1608282A4 (en) Methods for diagnosing skin lesions
AU2003254201A8 (en) Methods for performing transactions in a wireless environment
GB2416031B (en) A method and a kit for diagnosing cervical cancer
IL176376A0 (en) Method for analyzing a glycomolecule
GB0217782D0 (en) A method for determining pricing
AU2003263611A8 (en) Method for diagnosing prostate cancer
AU2003231220A8 (en) A method for detecting lysosomal storage diseases
AU2003283749A1 (en) Method for determining normal measurements for a patient
AU2003237573A8 (en) Method for wagering
AU2003214519A8 (en) Computed tomography method
AU2003288699A8 (en) Method for in vivo sensing
AU2003245105A8 (en) Method for diagnosing a tumor in a patient by determining pibf
AU2003294206A8 (en) Methods for diagnosing htlv-i-mediated diseases
GB0200757D0 (en) Diagnostic methods
AU2003301587A8 (en) Method for diagnosing renal diseases or predispositions
AU2003263004A8 (en) Radiotherapy method using x-rays
AU2003248625A8 (en) Methods for identifying ligands using waterlogsy nmr
GB0203768D0 (en) Diagnostic method for stroke
GB0324255D0 (en) Diagnostic method
GB0214842D0 (en) Diagnostic method
GB0201854D0 (en) Diagnostic method
GB0217628D0 (en) Diagnostic method
GB0217619D0 (en) Diagnostic method

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase